INVO Fertility (IVF) Stock Price, News & Analysis

Company Overview

INVO Fertility, Inc. is a medical technology and fertility services company focused on expanding access to in vitro fertilization (IVF) and related assisted reproductive technologies. The company’s primary product is INVOcell, an intravaginal culture system designed to incubate eggs and embryos inside a woman’s body during part of the IVF process, under the supervision of a fertility professional.

INVO Fertility seeks to make fertility treatment more accessible through a combination of medical devices, clinical services, and fertility centers. Its business model includes commercializing INVOcell, supporting clinics that use the technology, and developing or operating fertility treatment centers that provide services such as evaluation, egg retrieval, embryo culture, and embryo transfer.

The company was formerly known as INVO Bioscience and adopted the INVO Fertility name as it expanded its focus beyond device commercialization toward a broader fertility-care platform. INVOcell has received regulatory clearance in the United States and is also marketed in selected international markets, subject to applicable regulatory requirements. The company’s activities have primarily centered on the United States, with additional commercial and clinical opportunities pursued internationally.

Key Stats

• Today's Range: $0.93 to $0.97
• 50-Day Range: $0.91 to $1.53
• 52-Week Range: $0.90 to $84.40
• Volume: 91,425 shs
• Average Volume: 150,474 shs
• Market Capitalization: $2.34 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $20.00
• Consensus Rating: Moderate Buy

INVO Fertility Stock Analysis - MarketRank™

INVO Fertility scored higher than 58% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

INVO Fertility has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, no buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

INVO Fertility has a consensus price target of $20.00, representing about 2,042.2% upside from its current price of $0.93.

Amount of Analyst Coverage

INVO Fertility has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of INVO Fertility is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of INVO Fertility is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

INVO Fertility has a P/B Ratio of 0.27. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

7.76% of the float of INVO Fertility has been sold short.

Short Interest Ratio / Days to Cover

INVO Fertility has a short interest ratio ("days to cover") of 1.39, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in INVO Fertility has recently decreased by 47.30%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

INVO Fertility does not currently pay a dividend.

Dividend Growth

INVO Fertility does not have a long track record of dividend growth.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: 1.22

News Sentiment

INVO Fertility has a news sentiment score of 1.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for INVO Fertility this week, compared to 2 articles on an average week.

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, INVO Fertility insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.43% of the stock of INVO Fertility is held by insiders.

Percentage Held by Institutions

12.02% of the stock of INVO Fertility is held by institutions.

Company Calendar

• Last Earnings: 8/14/2026
• Today: 9/28/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:IVF
• Previous Symbol: NASDAQ:INVO
• CIK: 1417926
• Web: www.invobioscience.com
• Phone: (978) 878-9505
• Fax: N/A
• Employees: 46
• Year Founded: 2009

Price Target and Rating

• Average Price Target for INVO Fertility: $20.00
• High Price Target: $20.00
• Low Price Target: $20.00
• Potential Upside/Downside: +2,042.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($33.83)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$25.13 million
• Net Margins: -116.29%
• Pretax Margin: -93.56%
• Return on Equity: -85.54%
• Return on Assets: -31.05%

Debt

• Debt-to-Equity Ratio: 0.03
• Current Ratio: 0.71
• Quick Ratio: 0.67

Sales & Book Value

• Annual Sales: $6.84 million
• Price / Sales: 0.34
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.46 per share
• Price / Book: 0.27

Miscellaneous

• Outstanding Shares: 2,510,000
• Free Float: 2,496,000
• Market Cap: $2.34 million
• Optionable: No Data
• Beta: 2.34